Skip to content
MedsAcross

Molecule

Air polymer a intrauterine foam

Available on requestCold chain
Presentations
1
Brands
1
Manufacturers
1
Available from stock
0

Air polymer a intrauterine foam is a prescription medicine indicated for sonohysterosalpingography to assess fallopian tube patency in women with known or suspected infertility. It is available as kits for intrauterine use. MedsAcross supplies Air polymer a intrauterine foam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

US FDA first approval
Not recorded
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Intrauterine
Dosage forms
Kit

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

ExEm ® Foam is indicated for sonohysterosalpingography to assess fallopian tube patency in women with known or suspected infertility. ExEm ® Foam is an ultrasound contrast agent indicated for sonohysterosalpingography to assess fallopian tube patency in women with known or suspected infertility.

Source: US FDA prescribing information

How it works

ExEm Foam (air polymer-type A) intrauterine foam is formed by mixing the clear Gel [polymer-type A (hydroxyethyl cellulose), glycerin, and purified water] with air and Sterile Purified Water, creating an echogenic contrast agent. When visualized with ultrasound, the foam appears echogenic or bright within the fallopian tubes and peritoneal cavity.

Source: US FDA prescribing information

Dosing overview

Confirm the patient is not pregnant prior to ExEm Foam administrations. Recommended dose is 2 mL to 3 mL of ExEm Foam by intrauterine infusion using a 5-Fr or larger catheter. Dose may be repeated in 2 mL to 3 mL increments, as needed, to achieve visualization of the fallopian tubes. Maximum total dose is 10 mL. See Full Prescribing Information for preparation and administration instructions.

Source: US FDA prescribing information

Contraindications

ExEm Foam is contraindicated for use in: Pregnancy. Patients with known or suspected lower genital tract inflammation or infection. Patients who have had a gynecologic procedure within the last 30 days. Patients with vaginal bleeding Due to the risk of intravasation of ExEm Foam as a result of exposure of the endometrial vessels during bleeding, and Due to the potential risk of endometriosis as a result of seeding the peritoneum with endometrial tissue. Patients with known or suspected reproductive tract neoplasia due to the risk of peritoneal spread of neoplasm. ExEm Foam is contraindicated in: Pregnancy. Patients with vaginal bleeding.

Source: US FDA prescribing information

Warnings and precautions

Risk for fetal harm: Confirm that the patient has a negative pregnancy test within the 24 hours before ExEm Foam administration and confirm that the patient is in the pre-ovulatory phase of her menstrual cycle (cycle days 6 through 11). Risk for Post-Procedure Gynecologic Infections: Do not use in contraindicated situations even if the patient is receiving antimicrobial therapy.

Source: US FDA prescribing information

Side effects

Common adverse reactions are: pelvic and abdominal pain, vasovagal reactions and associated symptoms such as nausea and faintness, and post-procedure spotting.

Source: US FDA prescribing information

Storage

Store the kit and components at controlled room temperature between 20° to 25°C (68° to 77°F),, excursions permitted at 15° to 30°C (59° to 86°F). Do not store in refrigerator. Do not freeze.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

1 presentations of Air polymer a intrauterine foam, sorted by availability.

MedicineManufacturerRegisterAvailability
ExEm Foam kitIntrauterine Cold chainGiskit PharmaUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDANot recorded—
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Air polymer a intrauterine foam available for export from India?

Yes, on request. MedsAcross lists 1 presentations of Air polymer a intrauterine foam and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Air polymer a intrauterine foam have?

The catalogue lists 1 brand names for Air polymer a intrauterine foam, including ExEm Foam.

Does Air polymer a intrauterine foam need cold chain shipping?

At least one listed presentation of Air polymer a intrauterine foam must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.

References

  1. ExEm Foam prescribing information (Giskit Pharma). U.S. National Library of Medicine, DailyMed. Retrieved 8 November 2023

Request Air polymer a intrauterine foam for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.